Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Microenvironment-responsive multifunctional hydrogels with spatiotemporal sequential release of tailored recombinant human collagen type III for the rapid repair of infected chronic diabetic wounds

Cheng Hu a, Wenqi Liu a, Linyu Long a, Zhicun Wang a, Yihui Yuan a, Wen Zhang a, ShuYi He a, Jian Wang b, Li Yang *a, Lu Lu c and Yunbing Wang a
aNational Engineering Research Center for Biomaterials, Chuanda-Jinbo Joint Research Center, Sichuan University, Chengdu 610064, People's Republic of China. E-mail: yanglisc@scu.edu.cn; Tel: +86-28-85410280
bShanxi Jinbo Biomedicine Co., Ltd, Taiyuan 030000, People's Republic of China
cKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan-Jinbo Joint Research Center, Fudan University, Shanghai 200302, People's Republic of China

Received 13th December 2021 , Accepted 13th December 2021

First published on 22nd December 2021


Abstract

Correction for ‘Microenvironment-responsive multifunctional hydrogels with spatiotemporal sequential release of tailored recombinant human collagen type III for the rapid repair of infected chronic diabetic wounds’ by Cheng Hu et al., J. Mater. Chem. B, 2021, 9, 9684–9699, DOI: 10.1039/D1TB02170B.


The authors apologise for the mistakes made in Section 2.1. Materials and in the Acknowledgements of this article. The authors would like to correct the source of the tailored recombinant human collagen type III as this was incorrectly referenced in the article. The corrected sentence is as follows, ‘Our tailored recombinant human collagen type III (rhCol III) was prepared by Shanxi Jinbo Biomedicine Co., Ltd (Taiyuan, China), and the preparation process was the same as the previously reported method’.

The authors also wish to correct the acknowledgement regarding the funding for the rhCol III. The corrected acknowledgement is as follows, ‘Special thanks to Shanxi Jinbo Bio-Pharmaceutical Co., Ltd for their help in affording the as designed rhCol III.’

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2022
Click here to see how this site uses Cookies. View our privacy policy here.